| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | 13,536 | 13,286 |
| Cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), excluding exchange rate effect, including discontinued operation | 7,919 | - |
| Cash and cash equivalents at beginning of period | 8,740 | - |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect | - | 10,214 |
| Cash and cash equivalents at end of period | 16,688 | - |
Entera Bio Ltd. (ENTXW)
Entera Bio Ltd. (ENTXW)